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Propyl gallate (PG) used as an additive in various foods 
has antioxidant and anti-inflammatory effects. Although 
the functional roles of PG in various cell types are well 
characterized, it is unknown whether PG has effect on 
stem cell differentiation. In this study, we demonstrated 
that PG could inhibit adipogenic differentiation in human 
adipose tissue-derived mesenchymal stem cells (hAMSCs) 
by decreasing the accumulation of intracellular lipid drop-
lets. In addition, PG significantly reduced the expression 
of adipocyte-specific markers including peroxisome prolif-
erator-activated receptor-γ (PPAR-γ), CCAAT enhancer 
binding protein-α (C/EBP-α), lipoprotein lipase (LPL), and 
adipocyte fatty acid-binding protein 2 (aP2). PG inhibited 
adipogenesis in hAMSCs through extracellular regulated 
kinase (ERK) pathway. Decreased adipogenesis following 
PG treatment was recovered in response to ERK blocking. 
Taken together, these results suggest a novel effect of PG 
on adipocyte differentiation in hAMSCs, supporting a neg-
ative role of ERK1/2 pathway in adipogenic differentiation. 
 
 
INTRODUCTION 
1 
Propyl gallate (PG, 3,4,5-trihydroxybenzoic acid propyl ester, 
Fig. 1A), an ester formed by the condensation of gallic acid with 
n-propanol, is used as an antioxidant in a wide range of foods, 
cosmetics, hair products, adhesives, lubricants, food packing 
materials, pharmaceuticals, and personal hygiene products 
(Han et al., 2010). PG prevents fat oxidation as well as other 
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synthetic antioxidants such as butylated hydroxytoluene (BHT), 
butylated hydroxyanisole (BHA), tert-butyl hydroquinone (TBHQ), 
and ethylene diaminetetraacetic acid (EDTA) (Foti et al., 2010). In 
the food industry, PG is added to vegetable oil, mayonnaise, 
meat, soups, milk powder, spices, candies, snacks, vitamins, and 
chewing gums. It is practically used as a food additive (particular-
ly in oils and fats). It is authorized for use in Korea and many 
others countries (Daniel, 1986). Because of its prevalent usage, 
the potential toxicity of PG has been investigated in vivo (Dacre, 
1974; Wu et al., 1994) and in vitro to assess its various properties, 
including cytogenetic effects (Abdo et al., 1986) and mutagenicity 
(Rosin and Stich, 1980).  
Overweight and obesity defined as abnormal or excessive fat 
accumulation are major risk factors of several metabolic dis-
eases (such as type II diabetes, cardiovascular diseases, hy-
pertension) and certain cancers (Park et al., 2011). Obesity 
occurs when the calories ingested exceed the energy used. 
The excess calories end up in fat cells in the form of triglycer-
ides (Spiegelman and Flier, 2001). Obesity causes dysfunc-
tional production of adipokines and induces pro-inflammatory 
signaling pathways, leading to increase of inflammatory bi-
omarkers (Hotamisligil et al., 1993). Therefore, research has 
been conducted to identify novel factors with obesity-fighting 
effects from natural compounds (Bin and Choi, 2012).  
Mesenchymal stem cells (MSCs) are a group of multi-potent 
adult stem cells that can be isolated from various tissues, includ-
ing bone marrow, smooth muscle, adipose tissue, skeletal mus-
cle, trabecular bone, articular cartilage, umbilical cord blood, liver, 
spleen, and fetal tissue (Bianco et al., 2008; Chen et al., 2006; 
Lim et al., 2011; Mimeault and Batra, 2008). MSCs have several 
generations of self-renewal ability while maintaining their capacity 
to differentiate into multiple tissues. MSCs can be differentiated 
into the same mesenchymal lineage cells (such as osteocytes, 
chondrocytes, and adipocytes) and cells of other lineages such 
as neuronal and liver cells (Dezawa et al., 2004; 2005; Pan et al., 
2008; Pittenger et al., 1999). Because of these properties, MSCs 
have become an interesting target for potential therapeutic use in 
regenerative medicine and tissue engineering. Therefore, identi-
fying factors that regulate MSCs differentiation is essential to use 
these cells in regenerative medicine.  
Recent studies have shown that several compounds can 
modulate adipogenic differentiation by regulating MAPK activity, 
highlighting the central roles of MAPKs in adipocyte differentia-
tion. All three MAP kinases have been reported to be involved 
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in adipogenesis of hMSCs, with phosphorylation of ERK and JNK 
as negative regulator, whereas phosphorylation of p38 as posi-
tive regulator (Tominaga et al., 2005). PPAR-γ is a critical 
adipogenesis transcription factor (Rosen et al., 2000; Spiegelman, 
1998). However, the effect of PG on stem cell differentiation re-
mains unknown. In addition, it was unknown whether PG could 
activate MAPKs in adipogenesis of hMSCs. Therefore, the objec-
tives of this study were: 1) examine the effect of PG on 
adipogenic differentiation of hAMSCs; 2) determine whether PG 
could activate MAPKs. 
 
MATERIALS AND METHODS 
 
Materials 
PG, 3-isobutylmethylxanthine, dexamethasone, rosiglitazone, 
indometacin, insulin, methyl thiazolyltetrazolium (MTT), and Oil 
Red-O were purchased from Sigma-Aldrich (USA). Antibodies 
against CCAAT enhancer binding protein-α, peroxisome prolif-
erator-activated receptor-activated receptor-γ, ERK2, adipsin, 
and aP2 antibodies were obtained from Santa Cruz Biotech-
nology (USA). Antibodies against p-ERK1/2, p-p38, and p-JNK 
were purchased from Cell Signaling Technology (USA). Actin 
antibody was purchased from MP Biomedicals (USA). Anti-
mouse and anti-rabbit horseradish peroxidase-conjugated sec-
ondary antibodies were obtained from KPL (USA). PD98059 
was purchased from Calbiochem (USA). 
 
Cell culture  
Subcutaneous adipose tissues were obtained from women 
patients (mean age, 28 years) undergoing elective surgery after 
obtaining informed consent. hAMSCs were isolated from adi-
pose tissue according to a method described previously (Lee et 
al., 2004) with slight modifications. Briefly, hAMSCs were main-
tained in growth medium (GM) consisting of α-MEM supple-
mented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, 
and 100 mg/ml of streptomycin (Gibco BRL, USA). Passages 3 
to 10 were used in experiments.  
 
Adipogenic induction 
hAMSCs were grown to confluence before differentiation induc-
tion. Adipogenic differentiation was induced by culturing the 
hAMSCs for 14 days in adipogenic induction medium (AIM, 10% 
FBS, 1 μM dexamethasone, 500 μM 3-isobutyl-1-methylxanthine, 
1 μM insulin, and 100 μM indomethacin in α-MEM). After 6 days, 
cells were cultured in AIM containing only 10% FBS and 1 μM 
insulin in α-MEM. AIM was changed every 3 days.  
 
Oil Red-O staining 
Differentiated adipocytes were stained with Oil Red-O as an 
indicator of intracellular lipid accumulation. Cells were cultured 
in AIM as described above for 14 days. Lipid droplets within 
differentiated adipocytes from hAMSCs were observed using 
Oil Red-O staining method with modification. Briefly, cells were 
washed twice with phosphate buffered saline (PBS) and fixed 
with 4% paraformaldehyde for 2 h at 4°C. After two washes in 
PBS, cells were stained for 2 h in freshly diluted Oil Red-O 
solution (six parts of Oil Red-O stock solution and four parts of 
H2O). The Oil Red-O stock solution was 0.5% Oil Red-O in 
isopropanol at 4°C. The stain was then removed. Cells were 
washed twice with PBS. Images of cells stained with Oil Red-O 
were obtained with an Olympus IX 71 microscope equipped 
with an Olympus DP72 camera (Japan). For quantitative analy-
sis of Oil Red-O staining, cells were exposed to isopropanol for 
30 min. Absorbance value of the supernatant was measured at 
540 nm using a Biotrak II plate reader (Amersham Biosciences, 
Biochrom Ltd., Cambridge England). 
 
MTT assay 
hAMSCs were seeded at a density of 1 × 104cells/well into a 
96-well plate and cultured for appropriate length of time as 
indicated. MTT was dissolved in PBS at 5 mg/ml. The stock 
solution was filtered and added to the culture medium at a final 
concentration of 0.5 mg/ml. The plates were incubated at 37°C 
for 2 h. Dark brown formazan crystals formed after reduction of 
tetrazolium by mitochondria in living cells. The formazan crys-
tals were dissolved in dimethylsulfoxide (DMSO) and the ab-
sorbance values of the samples were measured at 540 nm. 
 
RNA extraction and real-time polymerase chain reaction 
(RT-PCR) 
Total RNA was extracted from hAMSCs using TRIzol reagent 
(Invitrogen, USA). cDNA was reverse-transcribed from 1.5 μg total 
cellular RNA using oligo(dT) primers and Moloney Murine Leuke-
mia Virus reverse transcriptase (Promega Corp., USA). cDNA was 
amplified using the following primers: peroxisome proliferator-
activated receptor gamma (PPAR-γ); CCAAT-enhancer-binding 
proteins (C/EBP)-α 5′-AACCTTGTGCCTTGGAAATG-3′ (sense), 
5′-CCTGCTCCCCTCCTTCTCT-3′ (antisense); adiponectin 5′-
ACCACTATGATGGCTCCACT-3′ (sense), 5′-GGTGAAGAGC- 
ATAGCCTTGT-3′ (antisense); fatty acid binding protein (aP2) 
5′-AACCTTAGATGGGGGTGTCCTG-3′ (sense), 5′-TCGTG- 
GAAGTGACGCCTTTC-3′ (antisense); lipoprotein lipase (LPL) 
5′-CTGGACGGTAACAGGAATGTATGAG-3′ (sense), 5′-CAT- 
CAGGAGAAAGACGACTCGG-3′ (antisense), and the refer-
ence gene, ribosomal protein large P0 (RPLP0) 5′-GGAATGT- 
GGGCTTTGTGTTC-3′ (sense), 5′-TGCCCCTGGAGATTTT- 
AGTG-3′ (antisense). For real-time PCR, total RNA (100 ng) 
was amplified with One Step SYBR RT-PCR kit using a Light 
Cycler 2.0 PCR system (Roche Diagnostics, Manheim, Germa-
ny). PCR conditions consisted of a 10-min hot start at 95°C, fol-
lowed by 45 cycles of 15 s at 95°C, 10 s at 60°C, and 30 s at 
72°C. mRNA expression levels were normalized against RPLP0 
expression. The experiment was repeated twice. 
 
Western blot analysis 
Whole cell lysates were prepared in lysis buffer (1% Triton X-
100, 10% glycerol, 150 mM NaCl, 50 mM HEPES, pH 7.3, 1 
mM EGTA, 1 mM sodium orthovanadate, 1 mM sodium fluoride, 
1 mM phenylmethysulfonyl fluoride, 10 mg/ml leupeptin, and 10 
mg/ml aprotinin). Lysates were then centrifuged at 14,000 rpm for 
15 min at 4°C. Electrophoresis was performed using 8~12% 
polyacrylamide gels. After proteins were electro-transferred to 
nitrocellulose membranes, they were incubated with primary 
antibodies overnight at 4°C. After incubation with appropriate 
peroxidase conjugated secondary antibody followed by washes, 
protein bands were detected with enhanced chemiluminescence 
system (ECL System, Amersham). 
 
Plasmids and luciferase activity assay 
Plasmid 3-x PPRE-tk-LUC containing three copies of PPAR-γ-
response element and pSV-PPAR-γ2 was used (Seo et al., 
2004). The pRL-SV40 construct, the Renilla luciferase expres-
sion vector, was purchased from Promega Corp. Human em-
bryonic kidney 293 (HEK293) cells were seeded into 24-well 
plates and cultured for 24 h before transfection. A DNA mixture 
containing the PPRE-luciferase reporter plasmid (0.1 μg), pSV-
PPAR-γ2 (0.1 μg), and an internal control plasmid pRL-SV-40 
(25 ng) was transfected using Lipofectamine transfection rea- 
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Fig. 1. Propyl gallate (PG) inhibits lipid accumulation in hAMSCs. 
(A) Chemical structure of PG; (B) Confluent hAMSCs were cultured 
in GM or AIM with various concentrations of PG. The media were 
changed every 3 days. Cells were stained with Oil Red-O on day 14. 
Red staining indicated the presence of neutral lipids. Images are 
representative of experiment performed in triplicates; (C) For quanti-
tative analysis, Oil Red-O staining was quantified by exposing the 
cells to isopropanol for 30 min. The absorbance of the supernatant 
was measured at 540 nm using a Biotrak II plate reader. Mean 
values were obtained from day 14 with the value of GM-cultured 
cells as 1.0. Other values were normalized against the value of GM-
cultured cells. Values are presented as mean ± SD. Error bars 
indicated the range of results. Experiment was performed in tripli-
cates. Results were representative of three independent experi-
ments (magnification × 100) (*p < 0.05); (D) Confluent hAMSCs 
were cultured in GM or AIM with or without 1~100 μM PG. Cells 
were harvested at the indicated times. Cell viability was examined 
by MTT assay. Values are presented as mean ± SD. Error bars 
indicate the range of results from experiment performed in tripli-
cates (*p < 0.05). Results are representative of three independent 
experiments. AIM: adipogenic induction medium; GM: growth me-
dium; hAMSCs: human adipose tissue-derived mesenchymal stem 
cells; MTT: methyl thiazolyltetrazolium; SD: standard deviation. 
 
 
 
gent according to the manufacturer’s recommendations. At 24 
h post transfection, cells were incubated for an additional 36 h 
following treatment with positive control or test materials. Lucif-
erase activity of cell lysates was measured using the Dual-
Luciferase Reporter Assay System (Promega) according to the 
manufacturer’s instructions. Relative luciferase activity was 
normalized to transfection efficiency using the corresponding 
Renilla luciferase activity. 
 
Statistical analysis 
Data were expressed as mean ± standard deviation (SD) of 
three or more independent experiments. Statistical significance 
was estimated by Student's t-test. Differences were considered 
significant when p value was less than 0.05. All statistical tests 
were performed using SPSS for Windows version 18.0 (SPSS, 
USA). 
 
RESULTS 
 
PG reduces lipid droplet formation 
hAMSCs were treated with AIM in the presence of PG to inves-
tigate the effect of PG on adipocyte differentiation. At 14 days 
after the initiation of differentiation, the accumulation of lipid 
droplets, a characteristic of the adipocyte formation process, 
was monitored using Oil Red-O staining. Major changes were 
observed in PG-treated hAMSCs compared to vehicle control-
treated hAMSCs under adipogenic differentiation conditions. 
Treatment with PG significantly (p < 0.05) reduced lipid droplets 
accumulation and adipocyte differentiation of hAMSCs in a 
dose-dependent manner (Fig. 1B). To further validate these 
phenotypic results, we measured the neutral lipid content in 
these cells and found that the neutral lipid content was signifi-
cantly (p < 0.05) decreased following PG treatment (Fig. 1C). 
These results indicated that PG suppressed adipogenesis in 
hAMSCs. In addition, we performed MTT assay to determine 
whether PG had cellular toxicity. MTT assay results revealed 
that PG did not affect the viability of cells cultured in AIM with 
up to 30 μM PG (Fig. 1D). Taken together, these results sug-
gest that PG could inhibit adipocyte differentiation without af-
fecting cellular toxicity. 
 
PG decreases mRNA levels and protein expression of 
adipogenic markers 
Adipocyte differentiation is accompanied by altered expression 
of various transcription factors and adipocyte-specific genes 
(Sermeus et al., 2008). To further confirm the effect of PG on 
adipocyte differentiation, we performed real-time PCR to de-
termine the expression of PPAR-γ and C/EBP-α, two key tran-
scriptional factors involved in adipogenesis. We also checked 
the mRNA expression levels of aP2, adiponectin, and LPL. The 
mRNA expression levels of PPAR-γ, C/EBP-α, LPL, aP2, and 
adiponectin were significantly (p < 0.05) decreased following 
treatment with 10 μM PG (Fig. 2A). At 6 days after PG treat-
ment, the mRNA expression levels of both PPAR-γ and C/EBP-
α expressions were significantly (p < 0.05) inhibited. The tran-
scriptional levels of aP2, adiponectin, and LPL were also signif-
icantly (p < 0.05) inhibited by PG treatment. In addition, the 
protein levels of adipocyte-specific markers were significantly (p 
< 0.05) decreased following PG treatment under adipogenic 
differentiation conditions (Fig. 2B). These results suggest that 
PG can inhibit adipocyte differentiation of hAMSCs. 
 
PG inhibits PPAR-γ activity 
PPAR-γ is a critical adipogenes is transcription factor (Rosen et 
al., 2000; Spiegelman, 1998). Some natural products can regu-
late adipogenesis by modulating PPAR-γ activity (Gong et al., 
2009; Saito et al., 2009; Shang et al., 2007). Based on these 
reports, we tested whether PG could inhibit adipocyte differentia-
tion by regulating PPAR-γ activity. Because the transfection effi-
ciency of hAMSCs was very low, we used HEK293 cells to ex-
amine the effect of PG on PPAR-γ activity. HEK293 cells were 
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Fig. 2. Propyl gallate (PG) decreases mRNA and protein level of 
adipocyte-specific markers. (A) hAMSCs were cultured in AIM with 
or without 10 μM PG. Gene expression of C/EBP-α, PPAR-γ, LPL, 
aP2, and adiponectin was examined by real-time PCR. The mean 
values obtained from vehicle-treated cells at 0 day were considered 
as 1.0. Others were relative values. Values are presented as mean 
± SD. Error bars indicate results range for treatment performed in 
triplicates. *p < 0.05 compared to control. Results are representa-
tive of two independent experiments; (B) PG decreases expression 
of adipocyte-specific marker proteins. Protein levels of adipogenic 
markers were examined during adipogenesis. Results are repre-
sentative of three independent experiments. aP2: adipocyte fatty 
acid-binding protein; C/EBP-α: CCAAT enhancer binding protein-α 
LPL, lipoprotein lipase; PCR: polymerase chain reaction; PPAR-γ: 
peroxisome proliferator-activated receptor-γ. 
 
 
 
co-transfected with a PPREx3-tk-luciferase reporter plasmid and 
PPAR-γ2 expression vector. We used rosiglitazone, a synthetic 
PPAR-γ ligand, as a positive control. At 36 h post treatment, 
rosiglitazone (100 nM) significantly (p < 0.05) increased the activi-
ty of PPAR-γ (Fig. 3). Co-treatment with PG reduced the tran-
scriptional activity of PPAR-γ in a dose-dependent manner (Fig. 
3). These results suggest that PG can suppress adipogenesis of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Propyl gallate (PG) inhibits PPAR-γ activity. HEK293 cells 
were co-transfected with PPREx3-tk-luciferase reporter plasmid, the 
Renilla luciferase plasmid, and the PPAR-γ2 expression vector. At 
12 h post transfection, cells were treated with 100 nM rosiglitazone 
and PG for 36 h. Ligand-dependent transcriptional activity was 
measured by dual-luciferase assay. Data are presented as the ratio 
of firefly luciferase activity to Renilla luciferase activity. Values are 
presented as mean ± SD. *p < 0.05 compared to control; PPAR-γ 
peroxisome proliferator-activated receptor-γ. 
 
 
 
hAMSCs by inhibiting PPAR-γ activity. 
 
PG negatively regulates adipogenic differentiation by  
activating ERK 
Recent studies have shown that several compounds can modu-
late adipogenic differentiation by regulating MAPK activity, high-
lighting the central roles of MAPKs in adipocyte differentiation. 
Based on these reports, we determined whether PG could acti-
vate MAPKs in hAMSCs. In serum starvation condition, PG (10 
M) induced ERK1/2 and p38 phosphorylation, but not JNK phos-
phorylation (Fig. 4A). In addition, treatment with PG (10 M) poten-
tiated ERK1/2 and p38 phosphorylation under AIM conditions 
compared to treatment with vehicle control (Figs. 4B and 4C). 
To determine whether PG could inhibit adipogenesis via the 
ERK or p38 signaling pathway, we used the specific mitogen-
activated protein kinase (MEK) inhibitor PD98059 to inhibit ERK 
phosphorylation. MEK is an upstream kinase of ERK. ERK 
activation can be prevented by blocking MEK activity(Crews et 
al., 1992). SB203580 was used to prevent p38 activation. PG-
induced ERK1/2 and p38 phosphorylation was significantly (p < 
0.05) inhibited in response to treatment by each inhibitor (Fig. 
5A). Treatment of PD98059 recovered PG-mediated inhibition 
of lipid accumulation in a dose-dependent manner (Fig. 5B), 
indicating that PG prevented adipogenic differentiation of 
hAMSCs via the ERK pathway. The absorbance of extracted 
Oil Red-O in the presence of PD98059 (20 μM) recovered to 
77% of that found under normal differentiating conditions (Fig. 
5B). In contrast, inhibiting the p38 signal pathway with the spe-
cific inhibitor SB203580 did not affect PG anti-adipogenic activi-
ty (Fig. 5B). Additionally, expressions of the adipocyte specific 
protein aP2 and adipsin were rescued in a dose dependent 
manner by inhibiting ERK (Fig. 5C). Our data clearly show that 
the ERK signaling pathway is required for anti-adipogenic ac-
tivity of PG. Taken together, these results suggest that PG 
inhibits adipogenesis possibly via sustained activation of ERK 
without depending on the activation of other MAPKs.
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Fig. 4. Propyl gallate (PG) activates phosphorylation of ERK1/2 and 
p38 in hAMSCs. (A) hAMSCs were treated with 10 μM PG under 
serum-free conditions. Cell lysates were prepared at different time 
points as indicated. ERK1/2, p38, and JNK1 phosphorylation was 
examined by immunoblotting; (B) hAMSCs were incubated with or 
without PG (10 μM) in AIM. Cell lysates were subjected to 
immunoblot analysis. ERK1/2 and p38 phosphorylation was stimu-
lated by PG treatment; (C) hAMSCs were treated with or without 
PG (10 μM) under adipogenic differentiation condition. ERK1/2 and 
p38 phosphorylations as well as ERK2 and β-actin expression were 
examined. β-actin was used as loading control. ERK: extracellular 
regulated kinase; JNK: Jun-kinase; hAMSCs: human adipose tis-
sue-derived mesenchymal stem cells; AIM: adipogenic induction 
medium. 
 
 
 
DISCUSSION 
 
PG has been used as a synthetic antioxidant in processed food, 
cosmetics, and food packaging materials to prevent rancidity 
and spoilage. It has also been used to preserve and stabilize 
medicines. Previous studies on PG have focused on its antioxi-
dant and anti-inflammatory effects. Several studies have re-
vealed the benefits of PG as antioxidant (Chen et al., 2007; 
Raghavan and Hultin, 2005; Reddan et al., 2003; Wu et al., 
1994), chemopreventive agent (Hirose et al., 1993; Karthikeyan 
et al., 2005), and anti-inflammatory agent (Jeon and Kim, 2007). 
However, the potential effect of PG on stem cell differentiation 
has not been studied yet previously. In this study, we focused 
on the activity of PG during hAMSC adipogenic differentiation. 
PG significantly decreased adipocyte differentiation of hAMSCs 
and 3T3-L1 cells (Supplementary Fig. 1) without cellular toxicity. 
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Fig. 5. Propyl gallate (PG) negatively regulates adipogenesis 
through ERK activation. (A) hAMSCs were pre-treated with vehicle 
or PD98059 for 1 h before the addition of AIM containing 10 μM PG. 
ERK1/2 phosphorylation was monitored by immunoblotting 30 min 
after PG treatment. hAMSCs were pre-treated with vehicle or 
SB203580 for 1 h before the addition of AIM containing 10 μM PG. 
p38 phosphorylation was monitored by immunoblotting 30 min after 
the PG treatment; (B) hAMSCs were cultured under adipogenic 
differentiation conditions with or without PG (10 μM). The effect of 
PD98059 or SB203580 was examined. Lipid accumulation was 
confirmed by Oil Red-O staining at 14 days after adipogenic induc-
tion. Values represent the mean ± SD; (C) The expression of 
adipogenic markers aP2 and adipsin was examined in PG-treated 
cells with or without treatment with PD98059; (D) aP2 protein levels 
in hAMSCs were examined at day 14 after adipogenic induction. 
The levels of aP2 were normalized to actin. hAMSCs: human adi-
pose tissue-derived mesenchymal stem cells; AIM: adipogenic 
induction medium; ERK: extracellular regulated kinase.
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Our results showed that PG inhibited adipocyte differentiation of 
hAMSCs and lipid droplet formation. Adipogenic marker ex-
pression was suppressed during adipogenesis of hAMSCs in 
response to PG treatment. In addition, PG reduced PPAR-γ 
activity. To our knowledge, this is the first report to demonstrate 
an effect of PG on stem cell differentiation.  
Many studies have shown that several compounds could neg-
atively regulate adipocyte differentiation. Genistein, an isoflavone 
derived from soybean, has been reported to be able to suppress 
adipogenic differentiation of hAMSCs through the Wnt/β-catenin 
signaling pathway (Kim et al., 2010b). Wedelolatone, an herbal 
medicine used to treat septic hick, has been reported to be 
capable of inhibiting adipogenic differentiation in bone marrow 
stromal cells by activating ERK and JNK (Lim et al., 2012). In 
addition, some flavonoids such as vitexin, orientin, and lovas-
tatin have been reported to be able inhibit adipogenic differenti-
ation by suppressing PPAR-γ expression in bone marrow-
derived mesenchymal cell cultures (Kim et al., 2010a; Li et al., 
2003). Our results suggest a novel effect of PG during 
adipogenesis in hAMSCs. In this study, it was found that PG 
could activate ERK1/2 phosphorylation. Blocking ERK activity 
rescued the inhibitory activity of PG during adipogenic differen-
tiation. Recently, it has demonstrated that multiple signaling 
pathways are implicated in adipogenesis (Tominaga et al., 
2005). MAPKs are involved in hMSCs adipogenesis, in which 
ERK and JNK are negative regulators, whereas p38 is a posi-
tive regulator (Tominaga et al., 2005). Activated PPAR-γ is a 
key regulator from the beginning of adipogenesis. ERK sup-
presses the PPAR-γ transcriptional activity (Camp and Tafuri, 
1997; Hu et al., 1996). Our results revealed that PG treatment 
could stimulate ERK phosphorylation under adipogenic differ-
entiating conditions, and that treatment with the MEK inhibitor 
PD98059 reversed the inhibitory effect of PG. These data sug-
gest that PG can suppress adipogenesis of hAMSCs by activat-
ing ERK. In addition, PG also decreased PPAR-γ activity. S112 
phosphorylation of PPAR-γ by ERK cascade has been reported 
to be able to not only inhibit RXR/PPAR heterodimers’ genomic 
action on PPREs, but also inhibit adipocyte differentiation 
(Camp and Tafuri, 1997). Therefore, activation of the ERK cas-
cade could contribute to the inhibition of PPAR-γ genomic ac-
tion through phosphorylation of PPAR-γ. The suppression of 
PPAR-γ activity might be mediated by ERK. Taken together, 
these results suggest that PG can inhibit adipogenesis via ERK 
pathway and the inhibition of PPAR-γ. 
In conclusion, we demonstrated a novel effect of PG during 
adipogenic differentiation of hAMSCs. PG inhibited lipid droplet 
formation and adipogenic marker expression in hAMSCs. Our 
results suggest that PG can inhibit adipogenesis of hAMSCs 
through the ERK signaling pathway, supporting a negative role 
of the ERK pathway in adipogenic differentiation.  
 
Note: Supplementary information is available on the Molecules 
and Cells website (www.molcells.org). 
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